Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

ClinicalTrials.gov ID: NCT00531427

Public ClinicalTrials.gov record NCT00531427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Placebo-controlled With Open-label Run-in Assessing Efficacy, Tolerability,Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects w/Moderate to Severe, Chronic Pain Due to OA of Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to determine the analgesic efficacy and safety of Buprenorphine Transdermal System (BTDS) 10 and 20 compared to placebo in opioid-naïve subjects with moderate to severe chronic pain due to osteoarthritis (OA) of the knee. The double-blind treatment intervention duration is 12 weeks, during which time supplemental analgesic medication (immediate-release oxycodone for the first 6 days postrandomization and acetaminophen or ibuprofen for the remainder of the double-blind phase) will be provided to all subjects in addition to study drug.

Study identification

NCT ID
NCT00531427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
567 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2007 (Type not available)
Primary completion
Apr 2009 (Actual)
Completion
Nov 2009 (Actual)
Last update posted
Sep 10, 2012

2007 – 2009

United States locations

U.S. sites
87
U.S. states
31
U.S. cities
76
Facility City State ZIP Site status
Coastal Clinical Research, Inc. Mobile Alabama 36608 —
Radiant Research, Phoenix Southeast Chandler Arizona 85225 —
Arizona Research Center, Inc. Phoenix Arizona 85023 —
Research Facility Phoenix Arizona 85029 —
Research Facility Phoenix Arizona 85032 —
Research Facility Anaheim California 92801 —
Lovelace Scientific Resources, Inc. Beverly Hills California 90211 —
Catalina Research Institute Chino California 91710 —
Research Facility Downey California 90241 —
Research Facility Foothill Ranch California 92610 —
Research Facility Laguna Hills California 92653 —
Research Facility Sacramento California 95831 —
Research Facility Littleton Colorado 80128 —
Research Facility Stamford Connecticut 06905 —
Coastal Pain Management Bradenton Florida 34209 —
Clinical Research of West Florida Clearwater Florida 33765 —
Research Facility Clearwater Florida 33765 —
Research Facility Jupiter Florida 33458-7200 —
Research Facility Largo Florida 33765 —
Pharmax Research Clinic Miami Florida 33126 —
Research Facility Miami Florida 33135 —
Research Facility Orlando Florida 32806 —
Research Facility Plantation Florida 33324 —
Research Facility Royal Palm Hammock Florida 33411 —
Clinical Research of West Flor Tampa Florida 33603 —
Research Facility Tampa Florida 33613 —
Research Facility Venice Florida 34292 —
Research Facility West Palm Beach Florida 33409 —
Research Facility Atlanta Georgia 30342 —
Research Facility Augusta Georgia 30901 —
AMR Research Associates Bogart Georgia 30622-6821 —
Research Facility Dawsonville Georgia 30534 —
Research Facility Decatur Georgia 30033 —
Research Facility Marietta Georgia 30066 —
Research Facility Honolulu Hawaii 96814-4526 —
Rehabilitation Association of IN Indianapolis Indiana 46250 —
Research Facility Overland Park Kansas 66211 —
Graves-Gilbert Clinic Bowling Green Kentucky 42101 —
Stat-Lab I, Inc. Baton Rouge Louisiana 70808 —
Research Facility New Iberia Louisiana 70563 —
Research Facility New Orleans Louisiana 70114 —
Research Facility Frederick Maryland 21702 —
Research Facility Brockton Massachusetts 02301 —
East Coast Clinical Research Haverhill Massachusetts 01830-6141 —
Research Facility Springfield Massachusetts 01103 —
Research Facility Bay City Michigan 48706 —
Premier Internal Medicine Biloxi Mississippi 39531 —
Research Facility Florissant Missouri 63031 —
Research Facility St Louis Missouri 63117 —
Sports Med Consultants PC St Louis Missouri 63141 —
Research Facility Henderson Nevada 89014 —
Research Facility New York New York 10004 —
Research Facility New York New York 10022 —
Research Facility Morgantown North Carolina 28655 —
Research Facility Winston-Salem North Carolina 27103 —
Research Facility Canton Ohio 44718 —
Research Facility Cincinnati Ohio 45242 —
Research Facility Columbus Ohio 43213 —
Research Facility Columbus Ohio 43235 —
Digestive Endoscopy Center Dayton Ohio 45415 —
Research Facility Dayton Ohio 45432 —
Research Facility Middleburg Heights Ohio 44130 —
Research Facility Mount Gilead Ohio 43338 —
Research Facility Toledo Ohio 43623 —
Research Facility Oklahoma City Oklahoma 73109 —
Research Facility Eugene Oregon 97404 —
Research Facility Medford Oregon 97504-8311 —
Paramount Clinical Research Bridgeville Pennsylvania 15017 —
Research Facility Duncansville Pennsylvania 16635 —
Oyster Point Family Health Ctr Lancaster Pennsylvania 17601 —
Research Facility Mechanicsburg Pennsylvania 17055 —
Research Facility West Reading Pennsylvania 19611 —
New England Center for Clinical Research Cranston Rhode Island 02920 —
Research Facility Cranston Rhode Island 02920 —
Greenville Pharmaceutical Research Greenville South Carolina 29415 —
Arthritis Clinic, PLLC Jackson Tennessee 38305 —
Research Facility Austin Texas 78756 —
Research Facility Colleyville Texas 76034 —
Research Facility Dallas Texas 75230 —
Research Facility Nederland Texas 77627 —
Research Facility San Antonio Texas 78205-1116 —
Research Facility San Antonio Texas 78229 —
Research Facility Sugarland Texas 77479 —
Research Facility Salt Lake City Utah 84102 —
NDC Medical Center Norfolk Virginia 23502 —
Independence Family Medicine Virginia Beach Virginia 23455 —
Pacific Northwest Primary Care Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00531427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2012 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00531427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →